CD36

protein-coding

CD36 molecule, the group of CD molecules|Scavenger receptors

Gene summary

The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]

MANE transcript

NM_001001548.3

Inheritance

AR

ClinVar variants

P:69U:147B:21

Top phenotype

Platelet glycoprotein IV deficiency

gnomAD constraint

pLI —, LoF o/e 2.82

Max pathogenic AF

—

Genomic locus

chr7:80,369,575-80,679,277

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~309.7 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

platelet-type bleeding disorder 10STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012031

Submitter: Labcorp Genetics (formerly Invitae)

platelet-type bleeding disorder 10STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0012031

Submitter: Laboratory for Molecular Medicine

This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.

Clinical Genomic Database (CGD)

Platelet glycoprotein IV deficiencyAR

Manifestation: Hematologic

Intervention: Hematologic

Rationale: Platelet glycoprotein IV deficiency has been reported with refractoriness to HLA-matched platelet transfusion, and may act as a susceptibility factor for hypertrophic cardiomyopathy and other cardiovascular-related parameters

Refs: 2617957; 10946357; 11247555; 15973412; 17668374; 17412877Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CD36 variants in ClinVar

11 Conditions Cataloged
Platelet-type bleeding disorder 10Total: 123
not specifiedTotal: 113
not providedTotal: 55
CD36-related disorderTotal: 42
Malaria, susceptibility toTotal: 10
Coronary heart disease, susceptibility to, 7Total: 9
OsteopetrosisTotal: 2
Inherited bleeding disorder, platelet-typeTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001001548.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
12
clinvar
18
missense
3
clinvar
4
clinvar
131
clinvar
7
clinvar
145
nonsense
4
clinvar
9
clinvar
1
clinvar
1
clinvar
15
start loss
0
frameshift
7
clinvar
23
clinvar
3
clinvar
1
clinvar
34
splice donor/acceptor (+/-2bp)
2
clinvar
17
clinvar
6
clinvar
25
Total1653147201237

Highest pathogenic variant AF is 0.00083733717

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 291 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001001548.3RefSeqNP_001001548.112MANE Select
ENST00000447544.7EnsemblENSP00000415743.212MANE Select
NM_000072.3RefSeqNP_000063.212Standard
NM_001001547.3RefSeqNP_001001547.112Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • ECM-receptor interaction - Homo sapiens (human)
  • Adipocytokine signaling pathway - Homo sapiens (human)
  • Insulin resistance - Homo sapiens (human)
  • Fat digestion and absorption - Homo sapiens (human)
  • Phagosome - Homo sapiens (human)

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • positive regulation of cell-matrix adhesion
  • toll-like receptor signaling pathway
  • antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
  • production of molecular mediator involved in inflammatory response

Molecular Function

  • amyloid-beta binding
  • low-density lipoprotein particle receptor activity
  • scavenger receptor activity
  • protein binding
  • high-density lipoprotein particle binding

Cellular Component

  • extracellular space
  • Golgi apparatus
  • plasma membrane
  • integral component of plasma membrane
  • external side of plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000435819
Coding exons
12
Length
309703
Individuals with no LoFs
121618
Homozygous LoFs
111
Heterozygous LoFs
4014
Defined
125743
p
0.0165
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-4.284372471.770.00001193093
Missense (PolyPhen)18979.7562.36971035
Synonymous-0.82810090.01.110.00000469887
Loss of Function-8.156623.42.829.88e-7311

Population LoF Frequency

PopulationCAFp-valueStatus
African0.180.17notable
Latino/Admixed American0.0100.010notable
Ashkenazi Jewish0.00410.0040notable
East Asian0.0230.023notable
Finnish0.000230.00023rare
European (Non-Finnish)0.00410.0041notable
South Asian0.00740.0072notable
Other0.0120.012notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Multifunctional glycoprotein that acts as receptor for a broad range of ligands. Ligands can be of proteinaceous nature like thrombospondin, fibronectin, collagen or amyloid-beta as well as of lipidic nature such as oxidized low-density lipoprotein (oxLDL), anionic phospholipids, long-chain fatty acids and bacterial diacylated lipopeptides. They are generally multivalent and can therefore engage multiple receptors simultaneously, the resulting formation of CD36 clusters initiates signal transduction and internalization of receptor-ligand complexes. The dependency on coreceptor signaling is strongly ligand specific. Cellular responses to these ligands are involved in angiogenesis, inflammatory response, fatty acid metabolism, taste and dietary fat processing in the intestine (Probable). Binds long-chain fatty acids and facilitates their transport into cells, thus participating in muscle lipid utilization, adipose energy storage, and gut fat absorption (By similarity) (PubMed:18353783, PubMed:21610069). In the small intestine, plays a role in proximal absorption of dietary fatty acid and cholesterol for optimal chylomicron formation, possibly through the activation of MAPK1/3 (ERK1/2) signaling pathway (By similarity) (PubMed:18753675). Involved in oral fat perception and preferences (PubMed:22240721, PubMed:25822988). Detection into the tongue of long-chain fatty acids leads to a rapid and sustained rise in flux and protein content of pancreatobiliary secretions (By similarity). In taste receptor cells, mediates the induction of an increase in intracellular calcium levels by long-chain fatty acids, leading to the activation of the gustatory neurons in the nucleus of the solitary tract (By similarity). Important factor in both ventromedial hypothalamus neuronal sensing of long-chain fatty acid and the regulation of energy and glucose homeostasis (By similarity). Receptor for thombospondins, THBS1 and THBS2, mediating their antiangiogenic effects (By similarity). As a coreceptor for TLR4:TLR6 heterodimer, promotes inflammation in monocytes/macrophages. Upon ligand binding, such as oxLDL or amyloid-beta 42, interacts with the heterodimer TLR4:TLR6, the complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion, through the priming and activation of the NLRP3 inflammasome (By similarity) (PubMed:20037584). Selective and nonredundant sensor of microbial diacylated lipopeptide that signal via TLR2:TLR6 heterodimer, this cluster triggers signaling from the cell surface, leading to the NF-kappa-B-dependent production of TNF, via MYD88 signaling pathway and subsequently is targeted to the Golgi in a lipid-raft dependent pathway (By similarity) (PubMed:16880211). {ECO:0000250|UniProtKB:Q07969, ECO:0000250|UniProtKB:Q08857, ECO:0000269|PubMed:16880211, ECO:0000269|PubMed:18353783, ECO:0000269|PubMed:18753675, ECO:0000269|PubMed:20037584, ECO:0000269|PubMed:21610069, ECO:0000269|PubMed:22240721, ECO:0000269|PubMed:25822988, ECO:0000305|PubMed:19471024}.;
Disease
DISEASE: Platelet glycoprotein IV deficiency (PG4D) [MIM:608404]: A disorder characterized by macrothrombocytopenia without notable hemostatic problems and bleeding tendency. Platelet glycoprotein IV deficiency can be divided into 2 subgroups. The type I phenotype is characterized by platelets and monocytes/macrophages exhibiting complete CD36 deficiency. The type II phenotype lacks the surface expression of CD36 in platelets, but expression in monocytes/macrophages is near normal. {ECO:0000269|PubMed:11950861, ECO:0000269|PubMed:7533783}. Note=The disease is caused by mutations affecting the gene represented in this entry. Patients also have postprandial hypertriglyceridemia, insulin resistance and hypertension increasing atherosclerotic risk. {ECO:0000269|PubMed:18753675}.; DISEASE: Coronary heart disease 7 (CHDS7) [MIM:610938]: A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. {ECO:0000269|PubMed:15282206}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.614
RVIS EVS
-1.7
RVIS percentile EVS
2.55

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.685

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.